Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03100656 · ClinicalTrials.gov registry record · NA
Study of Food Aversion in Patients With Anorexia Nervosa
A NA study of Anorexia Nervosa, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT03100656: Recruiting NA study of Anorexia Nervosa, sponsored by University of California, San Diego.
NCT03100656 is a NA study of Anorexia Nervosa that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 300 participants, below the 943-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03100656, a NA study of Anorexia Nervosa, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study uses a meal-challenge protocol to assess if patients with anorexia nervosa show a differential metabolism in response to food in comparison to healthy controls. This study determines how heritable and biochemical factors influence food metabolism in anorexia nervosa in order to develop more effective treatment strategies.
Primary Outcome
Percentage change of metabolism marker
Conditions Studied
Interventions
- OTHER A breakfast sandwich
Study Locations (2)
California
- UC San Diego Altman Clinical and Translational Research Institute - La Jolla
Ontario
- Program for Eating Disorders, Toronto General Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-11-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT03100656 shows while recruiting
NCT03100656 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 943-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which A breakfast sandwich is the first listed.
NCT03100656 reports a single indexed study location in California, Ontario.
Frequently Asked Questions
What is clinical trial NCT03100656 about?
NCT03100656 is a clinical study titled "Study of Food Aversion in Patients With Anorexia Nervosa". This study uses a meal-challenge protocol to assess if patients with anorexia nervosa show a differential metabolism in response to food in comparison to healthy controls. This study determines how heritable and biochemical factors influence food metabolism in anorexia nervosa in order to develop mo...
What is the current status of trial NCT03100656?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2016-11-10. Estimated completion is 2026-12-31.
What conditions does trial NCT03100656 study?
This clinical trial studies the following conditions: Anorexia Nervosa.
What interventions are being tested in trial NCT03100656?
The interventions under investigation include: A breakfast sandwich (OTHER).
Who is sponsoring clinical trial NCT03100656?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03100656 being conducted?
This trial has 2 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03100656's enrollment target sits among peer trials
300 3rd of 43 higher than 41 of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI